Novartis AG (NYSE:NVS)
| 85.89 Delayed Data As of Jun 05 |  +0.77 / +0.90%Today’s Change | 69.18 Today|||52-Week Range 99.84 | -9.29% Year-to-Date |
Latest NVS News | Press Releases
| Lonza Swipes a Top Roche Executive to Be Its Next CEO Jun 05 / MotleyFool.com - Paid Partner Content | The Debate Is Over: This Cancer Stock Is Winning the GIST Race Jun 03 / MotleyFool.com - Paid Partner Content |
| Pliant Therapeutics Up 33% on IPO Pricing Jun 03 / MotleyFool.com - Paid Partner Content | Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate May 28 / MotleyFool.com - Paid Partner Content |
| Better Buy: CRISPR Therapeutics vs. Intellia Jun 03 / MotleyFool.com - Paid Partner Content | Is Coherus BioSciences a Buy? May 26 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 85.12 |
| Today’s open | 85.67 |
| Day’s range | 85.54 - 86.44 |
| Volume | 1,533,296 |
| Average volume (3 months) | 2,578,938 |
| Market cap | $200.2B |
Data as of 4:00pm ET, 06/05/2020
Growth & Valuation
| Earnings growth (last year) | -43.54% |
| Earnings growth (this year) | +5.68% |
| Earnings growth (next 5 years) | +8.34% |
| Revenue growth (last year) | -8.60% |
| P/E ratio | 26.6 |
| Price/Sales | 4.62 |
| Price/Book | 3.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.03 | -0.08% |
| MRKMerck | +0.71 | +0.87% |
| ABBVAbbVie | +0.79 | +0.85% |
| LLYEli Lilly and Co | -1.50 | -1.00% |
Data as of 7:59pm ET, 06/05/2020
Financials
| Next reporting date | July 21, 2020 |
| EPS forecast (this quarter) | $1.39 |
| Annual revenue (last year) | $47.5B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 15.04% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
